The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology
Open accessAbstract
Parkinson's disease is caused by a progressive loss of the midbrain dopamine (DA) neurons in the substantia nigra pars compacta. Although the main cause of Parkinson's disease remains unknown, there is increasing evidence that it is a complex disorder caused by a combination of genetic and environmental factors, which affect key signalling pathways in substantia nigra DA neurons. Insights into pathogenesis of Parkinson's disease stem from in vitro and in vivo models and from postmortem analyses. Recent technological developments have added a new dimension to this research by determining gene expression profiles using high throughput microarray assays. However, many of the studies reported to date were based on whole midbrain dissections, which included cells other than DA neurons. Here, we have used laser microdissection to isolate single DA neurons from the substantia nigra pars compacta of controls and subjects with idiopathic Parkinson's disease matched for age and postmortem interval followed by microarrays to analyse gene expression profiling. Our data confirm a dysregulation of several functional groups of genes involved in the Parkinson's disease pathogenesis. In particular, we found prominent down-regulation of members of the PARK gene family and dysregulation of multiple genes associated with programmed cell death and survival. In addition, genes for neurotransmitter and ion channel receptors were also deregulated, supporting the view that alterations in electrical activity might influence DA neuron function. Our data provide a 'molecular fingerprint identity' of late-stage Parkinson's disease DA neurons that will advance our understanding of the molecular pathology of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Analyzing real-time PCR data by the comparative CT method
Schmittgen, T. D., & Livak, K. J. (2008) · Nature Protocols · doi:10.1038/nprot.2008.73 · Cited by 26,190
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Signal integration in the endoplasmic reticulum unfolded protein response
Ron, D., & Walter, P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2199 · Cited by 6,296
MOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE
Moore, D. J., West, A. B., Dawson, V. L., & Dawson, T. M. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135718 · Cited by 1,280
Doniger, S. W., Salomonis, N., Dahlquist, K. D., Vranizan, K., Lawlor, S. C., & Conklin, B. R. (2003) · Genome Biology · doi:10.1186/gb-2003-4-1-r7 · Cited by 865
Thomas, B., & Beal, M. F. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm159 · Cited by 748
THE BIOCHEMISTRY OF PARKINSON'S DISEASE
Cookson, M. R. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133400 · Cited by 664
Cell death in the nervous system
Bredesen, D. E., Rao, R. V., & Mehlen, P. (2006) · Nature · doi:10.1038/nature05293 · Cited by 636
Inflammation as a causative factor in the aetiology of Parkinson's disease
Whitton, P. S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707167 · Cited by 624
Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease
Boka, G., Anglade, P., Wallach, D., Javoy-Agid, F., Agid, Y., & Hirsch, E. C. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90684-x · Cited by 590
Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics
Mootha, V. K., Lepage, P., Miller, K., Bunkenborg, J., Reich, M., Hjerrild, M., Delmonte, T., Villeneuve, A., Sladek, R., Xu, F., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242716699 · Cited by 571
Molecular markers of early Parkinson's disease based on gene expression in blood
Scherzer, C. R., Eklund, A. C., Morse, L. J., Liao, Z., Locascio, J. J., Fefer, D., Schwarzschild, M. A., Schlossmacher, M. G., Hauser, M. A., Vance, J. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610204104 · Cited by 512
Mutations in the Na+/K+-ATPase α3 Gene ATP1A3 Are Associated with Rapid-Onset Dystonia Parkinsonism
de Carvalho Aguiar, P., Sweadner, K. J., Penniston, J. T., Zaremba, J., Liu, L., Caton, M., Linazasoro, G., Borg, M., Tijssen, M. A. J., Bressman, S. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.06.028 · Cited by 509
Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars
Benes, F. M., Lim, B., Matzilevich, D., Walsh, J. P., Subburaju, S., & Minns, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703806104 · Cited by 483
Self-citationThe pathogenesis of cell death in Parkinson's disease
Jenner, P., & Olanow, C. W. (2006) · Neurology · doi:10.1212/wnl.66.10_suppl_4.s24 · Cited by 446
Apoptosis in Parkinson's disease: Signals for neuronal degradation
Tatton, W. G., Chalmers-Redman, R., Brown, D., & Tatton, N. (2003) · Annals of Neurology · doi:10.1002/ana.10489 · Cited by 397
Gr�nblatt, E., Mandel, S., Jacob-Hirsch, J., Zeligson, S., Amariglo, N., Rechavi, G., Li, J., Ravid, R., Roggendorf, W., Riederer, P., et al. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0212-1 · Cited by 356
Structure and function of SNARE and SNARE-interacting proteins
Brunger, A. T. (2005) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583505004051 · Cited by 309
K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons
Liss, B., Haeckel, O., Wildmann, J., Miki, T., Seino, S., & Roeper, J. (2005) · Nature Neuroscience · doi:10.1038/nn1570 · Cited by 299
Calcium, ageing, and neuronal vulnerability in Parkinson's disease
Surmeier, D. J. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70246-6 · Cited by 297
Hartmann, A., Troadec, J.-D., Hunot, S., Kikly, K., Faucheux, B. A., Mouatt-Prigent, A., Ruberg, M., Agid, Y., & Hirsch, E. C. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-07-02247.2001 · Cited by 270
Martin, L. J., Liu, Z., Chen, K., Price, A. C., Pan, Y., Swaby, J. A., & Golden, W. C. (2007) · Journal of Comparative Neurology · doi:10.1002/cne.21160 · Cited by 269
Zhang, Y., James, M., Middleton, F. A., & Davis, R. L. (2005) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30195 · Cited by 258
Parkinson's disease : diagnosis and clinical management
Factor, S. A., & Weiner, W. J. (2002) · Cited by 254
Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson’s disease
Moran, L. B., Duke, D. C., Deprez, M., Dexter, D. T., Pearce, R. K. B., & Graeber, M. B. (2006) · neurogenetics · doi:10.1007/s10048-005-0020-2 · Cited by 242
Endocytosis: clathrin-mediated membrane budding
Ungewickell, E. J., & Hinrichsen, L. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.05.003 · Cited by 241
Effects of gender on nigral gene expression and parkinson disease
Cantuti-Castelvetri, I., Keller-McGandy, C., Bouzou, B., Asteris, G., Clark, T. W., Frosch, M. P., & Standaert, D. G. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.02.009 · Cited by 234
Ubiquitin–proteasome system and Parkinson's disease
Olanow, C. W., & McNaught, K. S. P. (2006) · Movement Disorders · doi:10.1002/mds.21013 · Cited by 212
The pathogenesis of cell death in Parkinson's disease – 2007
Olanow, C. W. (2007) · Movement Disorders · doi:10.1002/mds.21675 · Cited by 211
WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput data
Yi, M., Horton, J. D., Cohen, J. C., Hobbs, H. H., & Stephens, R. M. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-30 · Cited by 210
Self-citationGründemann, J., Schlaudraff, F., Haeckel, O., & Liss, B. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn084 · Cited by 174
RAZA, H., ROBIN, M.-A., FANG, J.-K., & AVADHANI, N. G. (2002) · Biochemical Journal · doi:10.1042/bj20020533 · Cited by 167
Hauser, M. A., Li, Y.-J., Xu, H., Noureddine, M. A., Shao, Y. S., Gullans, S. R., Scherzer, C. R., Jensen, R. V., McLaurin, A. C., Gibson, J. R., et al. (2005) · Archives of Neurology · doi:10.1001/archneur.62.6.917 · Cited by 158
Apoptotic neuronal death in Parkinson's disease: Involvement of nitric oxide
Singh, S., & Dikshit, M. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.02.001 · Cited by 146
Schiesling, C., Kieper, N., Seidel, K., & Krüger, R. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00952.x · Cited by 144
Luzzi, V. I., Mahadevappa, M., Raja, R. G., Warrington, J. A., & Watson, M. A. (2003) · Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60445-x · Cited by 138
What the future holds for deep brain stimulation
Benabid, A. L. (2007) · Expert Review of Medical Devices · doi:10.1586/17434440.4.6.895 · Cited by 130
Nicotinic receptors as CNS targets for Parkinson's disease
Quik, M., Bordia, T., & O’Leary, K. T. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.015 · Cited by 119
Pesticides and impairment of mitochondrial function in relation with the parkinsonian syndrome
Gómez, C., Bandez, M. J., & Navarro, A. (2006) · Frontiers in bioscience · doi:10.2741/2128 · Cited by 114
Lee, K.-H., Kim, M. Y., Kim, D.-H., & Lee, Y. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000026404.08779.43 · Cited by 112
Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease
Miller, R. M., Kiser, G. L., Kaysser-Kranich, T., Lockner, R., Palaniappan, C., & Federoff, H. J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.07.010 · Cited by 110
Miller, R. M., Callahan, L. M., Casaceli, C., Chen, L., Kiser, G. L., Chui, B., Kaysser-Kranich, T., Sendera, T. J., Palaniappan, C., & Federoff, H. J. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4204-03.2004 · Cited by 110
The soluble form of Fas molecule is elevated in parkinsonian brain tissues
Mogi, M., Harada, M., Kondo, T., Mizuno, Y., Narabayashi, H., Riederer, P. F., & Nagatsu, T. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13257-2 · Cited by 108
Moran, L. B., & Graeber, M. B. (2008) · Neurogenetics · doi:10.1007/s10048-007-0116-y · Cited by 102
Duke, D. C., Moran, L. B., Kalaitzakis, M. E., Deprez, M., Dexter, D. T., Pearce, R. K. B., & Graeber, M. B. (2006) · Neurogenetics · doi:10.1007/s10048-006-0033-5 · Cited by 95
Pathogenic effects of α-synuclein aggregation
Lundvig, D. M. S., Lindersson, E., & Jensen, P. H. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.09.001 · Cited by 94
Li, J., Smyth, P. C., Cahill, S., Denning, K. M., Flavin, R., Aherne, S. T., Pirotta, M., Guenther, S. M., O’Leary, J. J., & Sheils, O. M. (2008) · BMC Biotechnology · doi:10.1186/1472-6750-8-10 · Cited by 91
Deleterious Role of Superoxide Dismutase in the Mitochondrial Intermembrane Space
Goldsteins, G., Keksa-Goldsteine, V., Ahtoniemi, T., Jaronen, M., Arens, E., Åkerman, K. E. O., Chan, P. H., & Koıstınaho, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706111200 · Cited by 84
Fas and Fas‐L expression in Huntington's disease and Parkinson's disease
Ferrer, I., Blanco, R., Cutillas, B., & Ambrosio, S. (2000) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2000.00267.x · Cited by 62
FADD: A link between TNF family receptors and caspases in Parkinson’s disease
Hartmann, A., Prigent, A., Faucheux, B. A., Agid, Y., & Hirsch, É. C. (2002) · Neurology · doi:10.1212/wnl.58.2.308 · Cited by 60
Convergent Pathobiologic Model of Parkinson's Disease
Maguire‐Zeiss, K. A., & Federoff, H. J. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07473.x · Cited by 60
Koumanov, K. S., Momchilova, A., Quinn, P. J., & Wolf, C. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3630045 · Cited by 59
Role of activity‐dependent mechanisms in the control of dopaminergic neuron survival
Michel, P. P., Alvarez‐Fischer, D., Guerreiro, S., Hild, A., Hartmann, A., & Hirsch, É. C. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04424.x · Cited by 58
Moran, L. B., Croisier, E., Duke, D. C., Kalaitzakis, M. E., Roncaroli, F., Deprez, M., Dexter, D. T., Pearce, R. K. B., & Graeber, M. B. (2007) · Acta Neuropathologica · doi:10.1007/s00401-006-0181-6 · Cited by 55
G protein-activated inwardly rectifying potassium channels as potential therapeutic targets
Kobayashi, T., & Ikeda, K. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206779010468 · Cited by 53
Stirling, P. C., Srayko, M., Takhar, K. S., Pozniakovsky, A., Hyman, A. A., & Leroux, M. R. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-01-0069 · Cited by 53
Miller, R. M., & Federoff, H. J. (2005) · The Neuroscientist · doi:10.1177/1073858405278330 · Cited by 42
Programmed cell death and new discoveries in the genetics of parkinsonism
Burke, R. E. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05106.x · Cited by 37
Matsubayashi, H., Inoue, A., Amano, T., Seki, T., Nakata, Y., Sasa, M., & Sakai, N. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.06.040 · Cited by 37
Future directions in the treatment of Parkinson's disease
Schapira, A. H. V. (2007) · Movement Disorders · doi:10.1002/mds.21679 · Cited by 34
Multiple Functions of Mitochondria‐Shaping Proteins
Scorrano, L. (2007) · Novartis Foundation symposium · doi:10.1002/9780470725207.ch4 · Cited by 30
Lü, L., Neff, F., Alvarez‐Fischer, D., Henze, C., Hirsch, É. C., Oertel, W. H., Schlegel, J., & Hartmann, A. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.002 · Cited by 29
Gene expression profiles derived from single cells in human postmortem brain
Lü, L., Neff, F., Zhou, D. Y., Hemmer, B., Oertel, W. H., Schlegel, J., & Hartmann, A. (2004) · Brain Research Protocols · doi:10.1016/j.brainresprot.2003.12.003 · Cited by 22
Cited by
Selective neuronal vulnerability to oxidative stress in the brain
Wang (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00012 · Cited by 1,008
PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease
Zheng, B., Liao, Z., Locascio, J. J., Lesniak, K. A., Roderick, S. S., Watt, M. L., Eklund, A. C., Zhang-James, Y., Kim, P. D., Hauser, M. A., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001059 · Cited by 857
Favaloro, B., Allocati, N., Graziano, V., Di Ilio, C., & De Laurenzi, V. (2012) · Aging · doi:10.18632/aging.100459 · Cited by 585
Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities
Schmidt, M. F., Gan, Z. Y., Komander, D., & Dewson, G. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00706-7 · Cited by 368
MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration
Cebrián, C., Zucca, F. A., Mauri, P., Steinbeck, J. A., Studer, L., Scherzer, C. R., Kanter, E., Budhu, S., Mandelbaum, J., Vonsattel, J. P., et al. (2014) · Nature Communications · doi:10.1038/ncomms4633 · Cited by 338
Metadata
- Authors
- Simunovic, F., Yi, M., Wang, Y., Macey, L., Brown, L. T., Krichevsky, A. M., Andersen, S. L., Stephens, R. M., Benes, F. M., & Sonntag, K. C.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-12-03
- Volume
- 132
- Issue
- 7
- Pages
- 1795-1809
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2151704931
- Cited by
- 354
- References
- 65
- FWCI
- 11.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.